Kuan-Yin Lin1,2, Hui-Ching Cheng1, Chia-Jui Yen3, Ching-Hsia Hung1,2, Yu-Ting Huang1, Hsin-Lun Yang1,2, Wan-Ting Cheng1, Kun-Ling Tsai1,2. 1. Department of Physical Therapy, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan. 2. Institute of Allied Health Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan. 3. Division of Hematology and Oncology, Department of Internal Medicine, Graduate Institute of Clinical Medicine, National Cheng Kung University Hospital, Tainan 701, Taiwan.
Abstract
BACKGROUND:Cisplatin administration may induce muscle atrophy, thereby reducing the fitness level of patients with head and neck cancer (HNC). To date, only animal studies have been conducted to test the effectiveness of exercise interventions in diminishing side effects of cisplatin. AIM: To determine whether exercise training improves physical fitness and health-related quality of life (HRQoL) in patients receiving chemotherapy for Head & Neck (H&N). MATERIAL AND METHODS: This pilot-randomized controlled trial was conducted on 57 participants receiving chemotherapy for HNC. The participants were randomized into an exercise group and a control group. The exercise group received moderate-intensity combined aerobic, resistance and flexibility exercises three times a week for eight weeks during chemotherapy. The control group received no specific information regarding exercise. The outcome measures including body composition, muscle strength, balance, flexibility, cardiovascular fitness and health-related quality of life (HRQoL) were assessed at baseline and eight weeks following baseline. RESULTS: The body composition (body fat percentage, p = 0.002; skeletal muscle percentage, p = 0.008), dynamic balance (p = 0.01), muscle strength (upper extremity, p = 0.037; lower extremity, p = 0.025) and HRQoL (p = 0.001) showed a significant difference between the exercise group and the control group eight weeks following baseline. Significant deteriorations were noted in flexibility, muscle strength, cardiovascular fitness and several domains of HRQoL scale in the control group at eight weeks following baseline. CONCLUSIONS: This study found that a combined aerobic, resistance and flexibility exercise program during chemotherapy may improve physical fitness (i.e., muscle strength, balance, flexibility and body composition) and HRQoL and alleviate the deterioration of cardiovascular fitness in patients with HNC. Further research studies with large sample sizes are warranted to investigate the long-term effects of exercise in this population.
RCT Entities:
BACKGROUND:Cisplatin administration may induce muscle atrophy, thereby reducing the fitness level of patients with head and neck cancer (HNC). To date, only animal studies have been conducted to test the effectiveness of exercise interventions in diminishing side effects of cisplatin. AIM: To determine whether exercise training improves physical fitness and health-related quality of life (HRQoL) in patients receiving chemotherapy for Head & Neck (H&N). MATERIAL AND METHODS: This pilot-randomized controlled trial was conducted on 57 participants receiving chemotherapy for HNC. The participants were randomized into an exercise group and a control group. The exercise group received moderate-intensity combined aerobic, resistance and flexibility exercises three times a week for eight weeks during chemotherapy. The control group received no specific information regarding exercise. The outcome measures including body composition, muscle strength, balance, flexibility, cardiovascular fitness and health-related quality of life (HRQoL) were assessed at baseline and eight weeks following baseline. RESULTS: The body composition (body fat percentage, p = 0.002; skeletal muscle percentage, p = 0.008), dynamic balance (p = 0.01), muscle strength (upper extremity, p = 0.037; lower extremity, p = 0.025) and HRQoL (p = 0.001) showed a significant difference between the exercise group and the control group eight weeks following baseline. Significant deteriorations were noted in flexibility, muscle strength, cardiovascular fitness and several domains of HRQoL scale in the control group at eight weeks following baseline. CONCLUSIONS: This study found that a combined aerobic, resistance and flexibility exercise program during chemotherapy may improve physical fitness (i.e., muscle strength, balance, flexibility and body composition) and HRQoL and alleviate the deterioration of cardiovascular fitness in patients with HNC. Further research studies with large sample sizes are warranted to investigate the long-term effects of exercise in this population.
Entities:
Keywords:
chemotherapy; exercise training; head and neck cancer; muscle strength
Authors: Stephen Rajan Samuel; Arun G Maiya; Donald J Fernandes; Vasudeva Guddattu; P U Prakash Saxena; Jestina Rachel Kurian; Po-Ju Lin; Karen M Mustian Journal: Support Care Cancer Date: 2019-03-27 Impact factor: 3.603
Authors: Laura Q Rogers; Philip M Anton; Amanda Fogleman; Patricia Hopkins-Price; Steven Verhulst; Krishna Rao; James Malone; Randy Robbs; Kerry S Courneya; Parashar Nanavati; Sara Mansfield; K Thomas Robbins Journal: Head Neck Date: 2012-07-30 Impact factor: 3.147
Authors: J S Gewandter; L Fan; A Magnuson; K Mustian; L Peppone; C Heckler; J Hopkins; M Tejani; G R Morrow; S G Mohile Journal: Support Care Cancer Date: 2013-02-28 Impact factor: 3.603
Authors: F Streckmann; S Kneis; J A Leifert; F T Baumann; M Kleber; G Ihorst; L Herich; V Grüssinger; A Gollhofer; H Bertz Journal: Ann Oncol Date: 2014-02 Impact factor: 32.976
Authors: Sarah M Eickmeyer; Christine K Walczak; Katherine B Myers; D Richard Lindstrom; Peter Layde; Bruce H Campbell Journal: PM R Date: 2014-05-28 Impact factor: 2.298
Authors: Gopal Krishna Alaparthi; Kalyana Chakravarthy Bairappareddy; Omran Adil Al Bannay; Murtadha Massod Abdulrasool; Hanna Kassem; Ahad Fahad Al Zahrani; Asma Mohammad Ali; May Tamim Mohammed Journal: Asian Pac J Cancer Prev Date: 2022-03-01